Secondly, PANDER inhibits GLP-1 expression and secretion through the IL-6/JAK/STAT3/PI3K/Akt pathway, suggesting the presence of regulatory pathways among pancreatic factors, inflammatory factors, and gut hormones in glucose metabolism, providing a novel perspective for the prevention and treatment of diabetes. The gene discussed is AKT1; the disease is diabetes mellitus.